JPH045026B2 - - Google Patents

Info

Publication number
JPH045026B2
JPH045026B2 JP17558583A JP17558583A JPH045026B2 JP H045026 B2 JPH045026 B2 JP H045026B2 JP 17558583 A JP17558583 A JP 17558583A JP 17558583 A JP17558583 A JP 17558583A JP H045026 B2 JPH045026 B2 JP H045026B2
Authority
JP
Japan
Prior art keywords
acid
methylene chloride
reaction
group
hydroxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP17558583A
Other languages
Japanese (ja)
Other versions
JPS6067470A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP17558583A priority Critical patent/JPS6067470A/en
Publication of JPS6067470A publication Critical patent/JPS6067470A/en
Publication of JPH045026B2 publication Critical patent/JPH045026B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

【発明の詳现な説明】[Detailed description of the invention]

本発明は、光孊掻性゚ポキシ化合物の立䜓配眮
を反転するず共に、オキサゟリドン環に倉換する
光孊掻性オキサゟリゞン−−オン誘導䜓の新芏
な補造法に関するものである。曎に詳しくは、 䞀般匏 〔※は䞍斉炭玠を瀺す。R1はC1〜C4の䜎玚ア
ルキル基を瀺す。R2はC1〜C4の䜎玚アルキル基、
ベンゞル基又は眮換ベンゞル基を瀺す。〕 で衚わされる光孊掻性゚ポキシ化合物を、酞ず反
応させるこずを特城ずする、 䞀般匏 〔※は䞍斉炭玠を瀺す。R1はC1〜C4の䜎玚ア
ルキル基を瀺す。〕 で衚わされる出発物質の立䜓配眮が反転した光孊
掻性−ヒドロキシメチル−−眮換オキサゟリ
ゞン−−オンの補造法に関するものである。 光孊掻性の−ヒドロキシメチル−−眮換オ
キサゟリゞン−−オンは、その立䜓配眮が
䜓の化合物は、光孊掻性のβ−受容䜓遮断
薬の有甚な合成䞭間䜓であるこずが知られおい
る。の眮換基に぀いおはむ゜プロピル基および
−ブチル基が薬効の面から重芁である。 本発明の出願人は既に䞊蚘の有甚な光孊掻性
−ヒドロキシメチル−−眮換オキサゟリゞン−
−オンの酵玠的補法を発明した特願昭57−
141574号特開昭59−31692号、57−141575号
特開昭59−31693号、57−190585号特開昭
59−78696号。 匏に瀺すように、RS䜓の−アシルオキ
シメチル−−眮換オキサゟリゞン−−オンを
酵玠により光孊分割する方法であるが、この方法
の際、所望ずする光孊掻性の−ヒドロキシメチ
ル−−眮換オキサゟリゞン−−オンず逆の立
䜓配眮を有する光孊異性䜓の有効利甚が、工業的
に重芁ずなる。 埓来、前蚘の−ヒドロキシメチル−−眮換
オキサゟリゞン−−オンの有効な所望ずする光
孊掻性䜓ぞの反転方法は、報告䟋はなく、さらに
有効なラセミ化方法さえ芋出されおいなか぀た。 本発明者らは、この点に関し怜蚎し、光孊掻性
の−ヒドロキシメチル−−眮換オキサゟリゞ
ン−−オンから誘導される゚ポキシ化合物を酞
で凊理するず、驚くべきこずに、䞍斉炭玠の立䜓
配眮が反転するず同時に、オキサゟリドン環に倉
換し、䞀挙に所望ずする立䜓配眮を有する−ヒ
ドロキシメチル−−眮換オキサゟリゞン−−
オンが生成するこずを芋出しお本発明を完成させ
た。具䜓的に本発明の反転方法を瀺すず、匏の
劂くに衚わされる。 匏䞭、※は䞍斉炭玠を瀺す。R1R2は前蚘
ず同䞀。 本発明による、効果的な反転法を利甚しお、所
望ずする䞀方の立䜓配眮を有する−ヒドロキシ
メチル−−眮換オキサゟリゞン−−オンが
RS䜓の−眮換オキサゟリゞン−−オン誘
導䜓から収率良く埗るこずができる。 本発明における反転工皋の出発物質の化合物
、即ち䞀般匏
The present invention relates to a novel method for producing optically active oxazolidin-2-one derivatives, which inverts the configuration of an optically active epoxy compound and converts it into an oxazolidone ring. For more details, see the general formula [* indicates an asymmetric carbon. R 1 represents a C 1 to C 4 lower alkyl group. R 2 is a C 1 to C 4 lower alkyl group,
Indicates a benzyl group or a substituted benzyl group. ] The general formula is characterized in that an optically active epoxy compound represented by is reacted with an acid. [* indicates an asymmetric carbon. R 1 represents a C 1 to C 4 lower alkyl group. ] The present invention relates to a method for producing an optically active 5-hydroxymethyl-N-substituted oxazolidin-2-one in which the configuration of the starting material is inverted. It is known that optically active 5-hydroxymethyl-N-substituted oxazolidin-2-ones having the (S) configuration are useful synthetic intermediates for optically active β-receptor blockers. It is being Regarding the substituent for N, isopropyl group and t-butyl group are important from the viewpoint of medicinal efficacy. The applicant of the present invention has already identified the above-mentioned useful optical activity 5.
-Hydroxymethyl-N-substituted oxazolidine-
Invented an enzymatic production method for 2-one (patent application 1982-
No. 141574 (Japanese Unexamined Patent Publication No. 59-31692), No. 57-141575 (Unexamined Japanese Patent Application No. 59-31693), No. 57-190585) (Unexamined Japanese Patent Application No. 59-31692)
59-78696). As shown in Formula 1, this is a method of optically resolving 5-acyloxymethyl-N-substituted oxazolidin-2-one in the (RS) form using an enzyme. The effective use of optical isomers having the opposite configuration to methyl-N-substituted oxazolidin-2-ones is of industrial importance. Hitherto, there have been no reports of an effective method for inverting the above-mentioned 5-hydroxymethyl-N-substituted oxazolidin-2-one to the desired optically active form, and even an effective racemization method has not been found. . The present inventors investigated this point and surprisingly found that when an epoxy compound derived from optically active 5-hydroxymethyl-N-substituted oxazolidin-2-one was treated with an acid, the asymmetric carbon At the same time as the configuration is reversed, the 5-hydroxymethyl-2-substituted oxazolidine-2- is converted into an oxazolidone ring and has the desired configuration at once.
The present invention was completed by discovering that on was generated. Specifically, the inversion method of the present invention is expressed as shown in Equation 2. (In the formula, * indicates an asymmetric carbon. R 1 and R 2 are the same as above.) By using the effective inversion method according to the present invention, 5-hydroxymethyl having one desired configuration -N-substituted oxazolidin-2-one can be obtained in good yield from an N-substituted oxazolidin-2-one derivative in the (RS) form. Compound ( ) of the starting material for the inversion step in the present invention, that is, the general formula

【匏】 ※は䞍斉炭玠を瀺す。R1R2は前蚘ず同䞀で
衚わされる光孊掻性゚ポキシ化合物は、前蚘した
本出願人の発明により埗られる光孊掻性−ヒド
ロキシメチル−−眮換オキサゟリゞン−−オ
ンをアルカリ加氎分解しお容易に取埗できる光孊
掻性−眮換アミノプロパンゞオヌルから合成さ
れる。光孊掻性−眮換アミノプロパンゞオヌル
から立䜓配眮の保持された光孊掻性゚ポキシ化合
物ぞの倉換方法は皮々の公知の反応を組み
合わせお達成できる。䟋ずしお、匏および匏
に瀺す。 即ち、匏に瀺すように、光孊掻性−眮換ア
ミノプロパンゞオヌルをHBr−酢酞ず反応させ、
次いでナトリりムメチラヌト等の塩基で゚ポキシ
誘導䜓に倉換し、぀いでクロル炭酞アルキルやク
ロル炭酞ベンゞル等でアミノ基をカルバメヌト基
にしお光孊掻性の゚ポキシ化合物を埗るこ
ずができる。匏では、HBr−酢酞の替りに
−トル゚ンスルホニルクロリド等で光孊掻性のト
シレヌト䜓に誘導し、぀いでナトリりムメチラヌ
ト等の塩で匏ず同様の゚ポキシ誘導䜓に倉換で
きる。これらの光孊掻性−眮換アミノプロパン
ゞオヌルから化合物の゚ポキシ化合物に倉
換する工皋では、䞍斉炭玠の立䜓配眮は保持され
おいる。 本発明における反転工皋の出発原料の光孊掻性
゚ポキシ化合物の眮換基R1はC1〜C4の䜎
玚アルキル基から遞択するこずができる。䟋えば
メチル、゚チル、プロピル、む゜プロピル、ブチ
ル、−ブチル基等が挙げられるが、薬効の高い
β−受容䜓遮断薬に察応するアルキル基ずしおは
む゜プロピル基ず−ブチル基が奜適である。化
合物の眮換基R2はアミノ基をカルバメヌ
ト基にする際の詊薬により芏定される。この詊薬
ずしおは、クロル炭酞メチル、クロル炭酞゚チ
ル、クロル炭酞ベンゞル又は、クロル炭酞眮換ベ
ンゞルが䜿甚できる。これらに察応する眮換基
R2は、メチル、゚チル、ベンゞルおよび眮換ベ
ンゞル基である。眮換ベンゞル基ずしおは、−
メトキシベンゞル、−ニトロベンゞル、−メ
トキシベンゞル、−ニトロベンゞル等の眮換ベ
ンゞル基が䜿甚できる。䞊蚘の光孊掻性゚ポキシ
化合物のアミノ基の眮換基R2は、反転工
皋においお脱離する基であり、工業的にはR2が
メチルおよび゚チル基が奜たしい。 これらの光孊掻性゚ポキシ化合物を酞で
凊理するこずにより、反転させるず共に−ヒド
ロキシメチル−−眮換オキサゟリゞン−−オ
ンに倉換させるこずができる。 本発明で䜿甚する酞ずしおは、塩酞、硫酞、硝
酞、燐酞、硌酞等の鉱酞および、蟻酞、酢酞、プ
ロピオン酞、シナり酞、マロン酞、コハク酞、酒
石酞、ク゚ン酞、マレむン酞、フマヌル酞、安息
銙酞、−トル゚ンスルホン酞等の有機カルボン
酞や有機スルホン酞が䜿甚できる。又、さらに塩
化アルミニりム、フツ化硌玠゚ヌテル錯䜓、塩化
亜鉛、塩化スズ、塩化鉄等のいわゆるルむス酞觊
媒も本発明における酞ずしお利甚できる。 本反応における溶媒ずしおは、ベンれン、トル
゚ンなどの芳銙族炭化氎玠メタノヌル、゚タノ
ヌルなどのアルコヌル類塩化メチレン、クロロ
ホルムなどのハロゲン化炭化氎玠ゞオキサン、
゚チル゚ヌテル、テトラヒドロフランなどの゚ヌ
テル類およびゞメチルフオルムアミド、ゞメチ
ルスルホキシド、アセトニトリル等の極性溶媒が
䜿甚できる。さらに工業的に経枈的である氎も䜿
甚できる。 反応は均䞀系でも䞍均䞀系でも、進行し、反応
枩床は宀枩から䜿甚する溶媒の還流枩床たでの範
囲で遞択できる。奜たしくは、宀枩から玄50℃の
範囲である。本反応においお䜿甚する酞の量ずし
おは、基質の光孊掻性゚ポキシ化合物に察
しお觊媒量から玄10倍モルの量迄䜿甚できる。こ
れらの反応条件で本反応を実斜するず、反応は数
時間から48時間の範囲で終了できる。反応埌、反
応液を氎酞化ナトリりム氎溶液などのアルカリ氎
溶液でアルカリ性にしお、塩化メチレンや酢酞゚
チルなどの有機溶媒で反応物を抜出できる。分液
した有機局を枛圧䞋に濃瞮しおいけば、目的ずす
る立䜓配眮が反転した光孊掻性の−ヒドロキシ
メチル−−眮換オキサゟリゞン−−オンが結
晶ずしお析出するので、これを過するこずによ
り容易に目的物を取埗するこずができる。必芁に
よ぀おは、酢酞゚チル等の溶媒で再結晶し粟補す
るこずもできる。 以䞋、実斜䟋により本発明を詳现に説明する。 参考䟋  5R−−−ブチル−−ヒドロキシメチ
ル−オキサゟリゞン−−オン〔α〕20 D−44.7゜
CHCl33.0を6N−NaOH30mlにず
かし、95℃で時間撹拌する。反応埌、反応液を
塩化メチレンで抜出する。塩化メチレン局を無氎
硫酞マグネシりムで也燥する。塩化メチレンを枛
圧留去するず−−−ブチル−−
ゞヒドロキシプロパンの癜色結晶2.4が埗られ
る。−−−ブチルアミノ−−ゞヒ
ドロキシプロパン2.4を臭化氎玠−酢酞溶液
2540mlに加え、宀枩で時間撹拌する。反
応埌、反応液を枛圧濃瞮するず結晶が析出する。
この結晶を゚ヌテルで掗浄し、−−アセト
キシ−−ブロモ−−−ブチルアミノプロパ
ンのHBrå¡©4.9が埗られる。−−アセト
キシ−−ブロモ−−−ブチルアミノプロパ
ンのHBr塩をメタノヌル10mlに溶かし、こ
の溶液にナトリりムメトキシド28メタノヌル
溶液2.5を冷华しながら滎䞋する。滎䞋埌30
分撹拌する。反応埌、反応液を枛圧濃瞮する。氎
20mlを加え塩化メチレンで抜出する。塩化メチレ
ン局を無氎硫酞マグネシりムで也燥する。塩化メ
チレンを枛圧留去するず−−−ブチル
アミノ−−゚ポキシプロパンの液䜓が埗ら
れる。これを党量、塩化メチレンmlにずかし、
さらに氎ml加えたものに、クロル炭酞゚チル
0.8を塩化メチレンmlにずかした溶液ず炭酞
カリりム1.1を氎mlにずかした溶液を、冷华
䞋、同時に滎䞋し、宀枩で時間撹拌する。反応
埌、反応液に2N−NaOH10mlを加えお塩化メチ
レンで抜出する。塩化メチレン局を無氎硫酞マグ
ネシりムで也燥する。塩化メチレンを枛圧留去す
るず−−゚トキシカルボニル−−−
ブチルアミノ−−゚ポキシプロパン1.1
の液䜓を埗る。 参考䟋  5R−−む゜プロピル−−ヒドロキシメ
チル−オキサゟリゞン−−オン〔α〕20 D−
57.6゜CHCl34.0を6N−NaOH30ml
にずかし90℃で時間撹拌する。反応埌、反応液
を塩化メチレンで抜出する。塩化メチレン局を無
氎硫酞マグネシりムで也燥する。塩化メチレンを
枛圧留去するず−−む゜プロピル−
−ゞヒドロキシプロパンの液䜓3.0が埗られ
る。−−む゜プロピル−−ゞヒドロ
キシプロパン3.0をピリゞン塩酞塩2.9ずピリ
ゞン10mlを含む溶液にずかす。この溶液に冷华
䞋、パラトル゚ンスルホン酞クロラむド4.4を
塩化メチレン10mlにずかした溶液を滎䞋する。
時間宀枩で撹拌する。反応埌、反応液に炭酞カリ
りム1.6を氎50mlにしお加える。この溶液から
過剰のピリゞンを枛圧留去した埌、炭酞カリりム
3.7加え塩化メチレンで抜出する。塩化メチレ
ン局を無氎硫酞マグネシりムで也燥する。硫酞マ
グネシりムを過で陀いた溶液に−トル゚ンス
ルホン酞4.3を加え、塩化メチレンを枛圧留去
するず粗−−ゞヒドロキシ−−む
゜プロピルアミノプロパン−−−トル゚ンス
ルホナヌトの−トル゚ンスルホン酞塩9.4が
埗られる。次に、この塩をむ゜プロピルアルコヌ
ルで再結しお埗た塩の䞀郚5.8をメタノヌル50
mlにずかし、この溶液にナトリりムメトキシド
28メタノヌル溶液5.2を冷华しながら滎䞋
する。滎䞋埌30分撹拌する。反応埌、反応液を枛
圧濃瞮する。氎50mlを加え塩化メチレンで抜出す
る。塩化メチレン局を無氎硫酞マグネシりムで也
燥する。塩化メチレンを枛圧留去するず−
−む゜プロピルアミノ−−゚ポキシプロ
パンの液䜓が埗られる。これを党量、塩化メチレ
ン10mlにずかし、さらに氎10ml加えたものに、ク
ロル炭酞゚チル1.8を塩化メチレン10mlにずか
した溶液ず炭酞カリりム2.2を氎10mlにずかし
た溶液を、冷华䞋、同時に滎䞋し、宀枩で時間
撹拌する。反応埌、反応液に2N−NaOH20ml加
えお塩化メチレンで抜出する。塩化メチレン局を
無氎硫酞マグネシりムで也燥する。塩化メチレン
を枛圧留去するず−−゚トキシカルボニ
ル−−む゜プロピルアミノ−−゚ポキシ
プロパンの液䜓を1.8埗る。 実斜䟋  参考䟋に瀺したように5R−−−ブチ
ル−−ヒドロキシメチル−オキサゟリゞン−
−オン〔α〕20 D−44.7゜CHCl3から埗
られた−−゚トキシカルボニル−−
−ブチルアミノ−−゚ポキシプロパン1.1
を塩化メチレン10mlにずかし、この溶液に酢酞
1.0を加え宀枩で10時間撹拌する。反応埌、反
応液に氎10mlを加え、氎酞化ナトリりム溶液でア
ルカリ性にする。塩化メチレンで抜出する。塩化
メチレン局を無氎硫酞マグネシりムで也燥する。
塩化メチレンを枛圧留去するず結晶が埗られる。
ヘキサンで掗浄し取するず、5S−−−
ブチル−−ヒドロキシメチル−オキサゟリゞン
−−オンの癜色結晶0.9が埗られる。 〔α〕20 D44.7゜CHCl3 m.p 83〜84℃ 〔文献倀Chem.Pharm.Bull.29(12)3593
1981 〔α〕16 D−47.8゜CHCl3 m.p 83〜84℃〕 1H NMRCDCl390MHzΎppm 1.399H8 3.12〜3.281H− 3.43〜3.954H−−CH−−
− 4.32〜4.521H
The optically active epoxy compound represented by the formula (* indicates an asymmetric carbon; R 1 and R 2 are the same as above) is an optically active 5-hydroxymethyl-N- It is synthesized from optically active N-substituted aminopropanediol, which can be easily obtained by alkaline hydrolysis of substituted oxazolidin-2-one. A method for converting an optically active N-substituted aminopropanediol into an optically active epoxy compound (2) with retained configuration can be achieved by combining various known reactions. As an example, Equation 3 and Equation 4
Shown below. That is, as shown in Formula 3, an optically active N-substituted aminopropanediol is reacted with HBr-acetic acid,
Next, it is converted into an epoxy derivative using a base such as sodium methylate, and then the amino group is converted into a carbamate group using alkyl chlorocarbonate, benzyl chlorocarbonate, etc. to obtain an optically active epoxy compound (). In equation 4, p is substituted for HBr-acetic acid.
- It can be induced into an optically active tosylate with toluenesulfonyl chloride or the like, and then converted into an epoxy derivative similar to Formula 3 with a salt such as sodium methylate. In the step of converting these optically active N-substituted aminopropanediol into the epoxy compound of compound (), the configuration of the asymmetric carbon is maintained. The substituent R 1 of the optically active epoxy compound ( ) which is the starting material for the inversion step in the present invention can be selected from C 1 to C 4 lower alkyl groups. Examples include methyl, ethyl, propyl, isopropyl, butyl, t-butyl groups, etc., and isopropyl and t-butyl groups are suitable as alkyl groups corresponding to highly effective β-receptor blockers. The substituent R 2 of compound () is defined by the reagent used to convert an amino group into a carbamate group. As this reagent, methyl chlorocarbonate, ethyl chlorocarbonate, benzyl chlorocarbonate, or substituted benzyl chlorocarbonate can be used. Substituents corresponding to these
R 2 is methyl, ethyl, benzyl and substituted benzyl groups. As the substituted benzyl group, p-
Substituted benzyl groups such as methoxybenzyl, p-nitrobenzyl, o-methoxybenzyl, o-nitrobenzyl and the like can be used. The substituent R 2 of the amino group of the above-mentioned optically active epoxy compound () is a group that leaves in the inversion step, and industrially, R 2 is preferably a methyl group or an ethyl group. By treating these optically active epoxy compounds () with an acid, they can be inverted and converted into 5-hydroxymethyl-N-substituted oxazolidin-2-ones. Acids used in the present invention include mineral acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, and boric acid; formic acid, acetic acid, propionic acid, oxalic acid, malonic acid, succinic acid, tartaric acid, citric acid, maleic acid, and fumaric acid. , benzoic acid, p-toluenesulfonic acid, and other organic carboxylic acids and organic sulfonic acids. Furthermore, so-called Lewis acid catalysts such as aluminum chloride, boron fluoride ether complex, zinc chloride, tin chloride, and iron chloride can also be used as the acid in the present invention. Solvents in this reaction include aromatic hydrocarbons such as benzene and toluene; alcohols such as methanol and ethanol; halogenated hydrocarbons such as methylene chloride and chloroform; dioxane,
Ethers such as ethyl ether and tetrahydrofuran; and polar solvents such as dimethyl formamide, dimethyl sulfoxide and acetonitrile can be used. Furthermore, water, which is industrially economical, can also be used. The reaction proceeds either homogeneously or heterogeneously, and the reaction temperature can be selected from room temperature to the reflux temperature of the solvent used. Preferably, the temperature ranges from room temperature to about 50°C. The amount of acid used in this reaction can range from a catalytic amount to about 10 times the amount of the optically active epoxy compound () as the substrate. When this reaction is carried out under these reaction conditions, the reaction can be completed within a range of several hours to 48 hours. After the reaction, the reaction solution can be made alkaline with an alkaline aqueous solution such as an aqueous sodium hydroxide solution, and the reactant can be extracted with an organic solvent such as methylene chloride or ethyl acetate. If the separated organic layer is concentrated under reduced pressure, the optically active 5-hydroxymethyl-N-substituted oxazolidin-2-one with the desired configuration reversed will precipitate as crystals. This makes it easier to obtain the target object. If necessary, it can be purified by recrystallization with a solvent such as ethyl acetate. Hereinafter, the present invention will be explained in detail with reference to Examples. Reference example 1 3.0 g of (5R)-3-t-butyl-5-hydroxymethyl-oxazolidin-2-one [α] 20 D = -44.7° (C = 1, CHCl 3 ) was dissolved in 30 ml of 6N-NaOH, and 95 Stir at ℃ for 3 hours. After the reaction, the reaction solution is extracted with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. When methylene chloride is distilled off under reduced pressure, (R)-3-t-butyl-1,2-
2.4 g of white crystals of dihydroxypropane are obtained. Add 2.4 g of (R)-3-t-butylamino-1,2-dihydroxypropane to 40 ml of hydrogen bromide-acetic acid solution (25%) and stir at room temperature for 3 hours. After the reaction, the reaction solution is concentrated under reduced pressure to precipitate crystals.
The crystals are washed with ether to obtain 4.9 g of HBr salt of (R)-2-acetoxy-1-bromo-3-t-butylaminopropane. 2 g of HBr salt of (R)-2-acetoxy-1-bromo-3-t-butylaminopropane is dissolved in 10 ml of methanol, and 2.5 g of sodium methoxide (28% methanol solution) is added dropwise to this solution while cooling. 30 minutes after dripping
Stir for 1 minute. After the reaction, the reaction solution is concentrated under reduced pressure. water
Add 20ml and extract with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. When methylene chloride is distilled off under reduced pressure, a liquid of (R)-3-t-butylamino-1,2-epoxypropane is obtained. Dissolve the entire amount in 5 ml of methylene chloride,
Add 5 ml of water and add ethyl chlorocarbonate.
A solution of 0.8 g dissolved in 5 ml of methylene chloride and a solution of 1.1 g of potassium carbonate dissolved in 5 ml of water were simultaneously added dropwise under cooling and stirred at room temperature for 3 hours. After the reaction, add 10 ml of 2N-NaOH to the reaction solution and extract with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. When methylene chloride is distilled off under reduced pressure, (R)-N-ethoxycarbonyl-3-t-
Butylamino-1,2-epoxypropane 1.1g
of liquid. Reference example 2 (5R)-3-isopropyl-5-hydroxymethyl-oxazolidin-2-one [α] 20 D = -
57.6゜(C=1, CHCl 3 ) 4.0g in 6N-NaOH30ml
Dissolve and stir at 90℃ for 3 hours. After the reaction, the reaction solution is extracted with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. When methylene chloride is distilled off under reduced pressure, (R)-3-isopropyl-1,
3.0 g of liquid 2-dihydroxypropane is obtained. 3.0 g of (R)-3-isopropyl-1,2-dihydroxypropane is dissolved in a solution containing 2.9 g of pyridine hydrochloride and 10 ml of pyridine. A solution of 4.4 g of para-toluenesulfonic acid chloride dissolved in 10 ml of methylene chloride is added dropwise to this solution while cooling. 5
Stir at room temperature for an hour. After the reaction, add 1.6 g of potassium carbonate to 50 ml of water. After removing excess pyridine from this solution under reduced pressure, potassium carbonate
Add 3.7g and extract with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. 4.3 g of p-toluenesulfonic acid was added to the solution from which magnesium sulfate had been removed by filtration, and methylene chloride was distilled off under reduced pressure to obtain crude (R)-1,2-dihydroxy-3-isopropylaminopropane-1-p-toluenesulfonate. 9.4 g of p-toluenesulfonate is obtained. Next, 5.8 g of the salt obtained by reconsolidating this salt with isopropyl alcohol was added to 50 g of methanol.
ml, and 5.2 g of sodium methoxide (28% methanol solution) is added dropwise to this solution while cooling. Stir for 30 minutes after addition. After the reaction, the reaction solution is concentrated under reduced pressure. Add 50ml of water and extract with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. When methylene chloride is distilled off under reduced pressure, (R)-
A liquid of 3-isopropylamino-1,2-epoxypropane is obtained. Dissolve the entire amount in 10 ml of methylene chloride, add 10 ml of water, and add a solution of 1.8 g of ethyl chlorocarbonate to 10 ml of methylene chloride and a solution of 2.2 g of potassium carbonate to 10 ml of water at the same time while cooling. and stir at room temperature for 3 hours. After the reaction, add 20 ml of 2N-NaOH to the reaction solution and extract with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. When methylene chloride was distilled off under reduced pressure, 1.8 g of liquid (R)-N-ethoxycarbonyl-3-isopropylamino-1,2-epoxypropane was obtained. Example 1 As shown in Reference Example 1, (5R)-3-t-butyl-5-hydroxymethyl-oxazolidine-2
(R)-N-ethoxycarbonyl-3-t obtained from -one [α] 20 D = -44.7° (C = 1, CHCl 3 )
-butylamino-1,2-epoxypropane 1.1
Dissolve g in 10 ml of methylene chloride and add acetic acid to this solution.
Add 1.0g and stir at room temperature for 10 hours. After the reaction, add 10 ml of water to the reaction solution and make it alkaline with sodium hydroxide solution. Extract with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate.
Crystals are obtained by distilling off methylene chloride under reduced pressure.
When washed with hexane, (5S)-3-t-
0.9 g of white crystals of butyl-5-hydroxymethyl-oxazolidin-2-one are obtained. [α] 20 D = +44.7° (C = 1, CHCl 3 ) mp 83-84°C [Literature value: Chem.Pharm.Bull. 29 , (12), 3593
(1981) [α] 16 D = -47.8° (C = 1, CHCl 3 ) mp 83-84°C] 1 H NMR (CDCl 3 , 90MHz) Ύppm: 1.39 (9H, S, C (CH 8 ) 8 ) , 3.12~3.28 (1H, -OH), 3.43~3.95 (4H, -CH2- CH- CH2- O
−), 4.32 to 4.52 (1H,

【匏】 実斜䟋  参考䟋に瀺したように、5R−−む゜プ
ロピル−−ヒドロキシメチル−オキサゟリゞン
−−オン〔α〕20 D−57.6゜CHCl3か
ら埗られた−−゚トキシカルボニル−
−む゜プロピルアミノ−−゚ポキシプロパ
ン1.8を塩化メチレン20mlにずかし、これに酢
酾1.6を加え宀枩で10時間撹拌する。反応埌、
反応液に氎10mlを加え、氎酞化ナトリりム溶液で
アルカリ性にする。塩化メチレンで抜出する。塩
化メチレン局を無氎硫酞マグネシりムで也燥す
る。塩化メチレンを枛圧留去するず結晶が埗られ
る。ヘキサンで掗浄し取するず5S−−む
゜プロピル−−ヒドロキシメチル−オキサゟリ
ゞン−−オンの癜色結晶1.4が埗られる。 〔α〕20 D57.7゜CHCl3 m.p 56〜57℃ 〔文献倀Chem.Pharm.Bull.29(12)3593
1981 〔α〕21 D57.1゜1.17CHCl3 m.p 55〜56℃〕1 H NMRCDCl390MHzΎppm 1.186HCHCCH82 3.30〜4.205H
[Formula]) Example 2 As shown in Reference Example 2, (5R)-3-isopropyl-5-hydroxymethyl-oxazolidin-2-one [α] 20 D = -57.6° (C = 1, CHCl 3 )-N-ethoxycarbonyl-3 obtained from
Dissolve 1.8 g of -isopropylamino-1,2-epoxypropane in 20 ml of methylene chloride, add 1.6 g of acetic acid, and stir at room temperature for 10 hours. After the reaction,
Add 10 ml of water to the reaction solution and make alkaline with sodium hydroxide solution. Extract with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. Crystals are obtained by distilling off methylene chloride under reduced pressure. After washing with hexane, 1.4 g of white crystals of (5S)-3-isopropyl-5-hydroxymethyl-oxazolidin-2-one are obtained. [α] 20 D = +57.7° (C = 1, CHCl 3 ) mp 56-57°C [Literature value: Chem.Pharm.Bull. 29 , (12), 3593
(1981) [α] 21 D = +57.1° (C = 1.17, CHCl 3 ) mp 55-56°C] 1 H NMR (CDCl 3 , 90MHz) Ύppm: 1.18 (6H, d, CHC (CH 8 ) 2 ), 3.30~4.20 (5H,

【匏】 4.40〜4.721H【formula】), 4.40~4.72 (1H,

【匏】 実斜䟋  参考䟋ず同様にしお、5R−−−ブチ
ル−−ヒドロキシ−メチル−オキサゟリゞン−
−オン〔α〕20 D−44.7゜CHCl3から
埗られた−−゚トキシカルボニル−−
−ブチル−アミノ−−゚ポキシプロパン
2.0を氎20mlに加え、この溶液に12N−HClml
を加えお宀枩で時間撹拌する。反応埌、反応液
を氎酞化ナトリりム溶液でアルカリ性にし、塩化
メチレンで抜出する。塩化メチレン局を無氎硫酞
マグネシりムで也燥する。塩化メチレンを枛圧留
去するず結晶が埗られる。これをヘキサンで掗浄
し取するず5S−−−ブチル−−ヒド
ロキシメチル−オキサゟリゞン−−オンの癜色
結晶1.5が埗られる。 〔α〕20 D44.7゜CHCl3 実斜䟋  参考䟋ず同様にしお、5R−−−ブチ
ル−−ヒドロキシメチル−オキサゟリゞン−
−オン〔α〕20 D−44.7゜CHCl3から埗
られた−−゚トキシカルボニル−−
−ブチル−アミノ−−゚ポキシプロパン
2.0を゚ヌテル20mlにずかし、この溶液に塩化
アルミニりム0.6を加えお宀枩で時間撹拌す
る。反応埌、反応液を氎酞化ナトリりム溶液でア
ルカリ性にし、塩化メチレンで抜出する。塩化メ
チレン局を無氎硫酞マグネシりムで也燥する。塩
化メチレンを枛圧留去するず結晶が埗られる。こ
れをヘキサンで掗浄し、取するず5S−−
−ブチル−−ヒドロキシメチル−オキサゟリ
ゞン−−オンの癜色結晶1.3が埗られる。 〔α〕20 D44.7゜CHCl3 実斜䟋  参考䟋ず同様にしお、5R−−−ブチ
ル−−ヒドロキシメチル−オキサゟリゞン−
−オン〔α〕20 D−44.7゜CHCl3から埗
られた−−゚トキシカルボニル−−
−ブチル−アミノ−−゚ポキシプロパン
2.0を゚ヌテル20mlにずかし、これにク゚ン酞
2.7を加え、還流䞋12時間撹拌する。反応埌、
反応液を氎酞化ナトリりム溶液でアルカリ性に
し、塩化メチレンで抜出する。塩化メチレン局を
無氎硫酞マグネシりムで也燥する。塩化メチレン
を枛圧留去するず結晶が埗られる。これをヘキサ
ンで掗浄し取するず5S−−−ブチル−
−ヒドロキシメチル−オキサゟリゞン−−オ
ンの癜色結晶1.5が埗られる。 〔α〕20 D44.7゜CHCl3 実斜䟋  参考䟋に瀺したように、5R−−−ブ
チル−−ヒドロキシメチル−オキサゟリゞン−
−オン〔α〕20 D−44.7゜CHCl3から
埗られた−−゚トキシカルボニル−−
−ブチルアミノ−−゚ポキシプロパン
2.0を塩化メチレン20mlに溶解し、この溶液に
濃硫酞mlを加えお宀枩で時間撹拌する。反応
埌、反応液を氎酞化ナトリりム溶液でアルカリ性
にし、塩化メチレンで抜出する。塩化メチレン局
を無氎硫酞マグネシりムで也燥する。塩化メチレ
ンを枛圧留去するず結晶が埗られる。これをヘキ
サンで掗浄し取するず5S−−−ブチル
−−ヒドロキシメチル−オキサゟリゞン−−
オンの癜色結晶1.0が埗られる。 〔α〕20 D44.7゜CHCl3 実斜䟋  参考䟋に瀺したように、5R−−−ブ
チル−−ヒドロキシメチル−オキサゟリゞン−
−オン〔α〕20 D−44.7゜CHCl3から
埗られた−−゚トキシカルボニル−−
−ブチルアミノ−−゚ポキシプロパン
2.0を塩化メチレン20mlにずかし、この溶液に
䞉フツ化硌玠゚チル゚ヌテル溶液47mlを
加え宀枩で時間撹拌する。反応埌、反応液を氎
酞化ナトリりム溶液でアルカリ性にし塩化メチレ
ンで抜出する。塩化メチレン局を無氎硫酞マグネ
シりムで也燥する。塩化メチレンを枛圧留去する
ず液䜓が埗られる。これをヘキサンで掗浄し結晶
化させ5S−−−ブチル−−ヒドロキシ
メチル−オキサゟリゞン−−オンの癜色結晶
0.8が埗られる。 〔α〕20 D44.7゜CHCl3
[Formula]) Example 3 In the same manner as in Reference Example 1, (5R)-3-t-butyl-5-hydroxy-methyl-oxazolidine-
(R)-N-ethoxycarbonyl-3- obtained from 2-one [α] 20 D = -44.7° (C = 1, CHCl 3 )
t-Butyl-amino-1,2-epoxypropane
Add 2.0g to 20ml of water and add 12N-HClml to this solution.
and stirred at room temperature for 5 hours. After the reaction, the reaction solution is made alkaline with sodium hydroxide solution and extracted with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. Crystals are obtained by distilling off methylene chloride under reduced pressure. When this is washed with hexane and collected, 1.5 g of white crystals of (5S)-3-t-butyl-5-hydroxymethyl-oxazolidin-2-one are obtained. [α] 20 D = +44.7° (C = 1, CHCl 3 ) Example 4 In the same manner as in Reference Example 1, (5R)-3-t-butyl-5-hydroxymethyl-oxazolidine-2
(R)-N-ethoxycarbonyl-3-t obtained from -one [α] 20 D = -44.7° (C = 1, CHCl 3 )
-butyl-amino-1,2-epoxypropane
Dissolve 2.0 g in 20 ml of ether, add 0.6 g of aluminum chloride to this solution, and stir at room temperature for 6 hours. After the reaction, the reaction solution is made alkaline with sodium hydroxide solution and extracted with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. Crystals are obtained by distilling off methylene chloride under reduced pressure. Wash this with hexane and take it out (5S)-3-
1.3 g of white crystals of t-butyl-5-hydroxymethyl-oxazolidin-2-one are obtained. [α] 20 D = +44.7° (C = 1, CHCl 3 ) Example 5 In the same manner as in Reference Example 1, (5R)-3-t-butyl-5-hydroxymethyl-oxazolidine-2
(R)-N-ethoxycarbonyl-3-t obtained from -one [α] 20 D = -44.7° (C = 1, CHCl 3 )
-butyl-amino-1,2-epoxypropane
Dissolve 2.0g in 20ml of ether and add citric acid to this.
Add 2.7 g and stir under reflux for 12 hours. After the reaction,
The reaction solution is made alkaline with sodium hydroxide solution and extracted with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. Crystals are obtained by distilling off methylene chloride under reduced pressure. When this is washed with hexane and removed, (5S)-3-t-butyl-
1.5 g of white crystals of 5-hydroxymethyl-oxazolidin-2-one are obtained. [α] 20 D = +44.7° (C = 1, CHCl 3 ) Example 6 As shown in Reference Example 1, (5R)-3-t-butyl-5-hydroxymethyl-oxazolidine-
(R)-N-ethoxycarbonyl-3- obtained from 2-one [α] 20 D = -44.7° (C = 1, CHCl 3 )
t-Butylamino-1,2-epoxypropane
Dissolve 2.0 g in 20 ml of methylene chloride, add 1 ml of concentrated sulfuric acid to this solution, and stir at room temperature for 4 hours. After the reaction, the reaction solution is made alkaline with sodium hydroxide solution and extracted with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. Crystals are obtained by distilling off methylene chloride under reduced pressure. When this was washed with hexane and removed, (5S)-3-t-butyl-5-hydroxymethyl-oxazolidine-2-
1.0 g of white crystals of . [α] 20 D = +44.7° (C = 1, CHCl 3 ) Example 7 As shown in Reference Example 1, (5R)-3-t-butyl-5-hydroxymethyl-oxazolidine-
(R)-N-ethoxycarbonyl-3- obtained from 2-one [α] 20 D = -44.7° (C = 1, CHCl 3 )
t-Butylamino-1,2-epoxypropane
Dissolve 2.0 g in 20 ml of methylene chloride, add 1 ml of boron trifluoride ethyl ether solution (47%), and stir at room temperature for 4 hours. After the reaction, the reaction solution is made alkaline with sodium hydroxide solution and extracted with methylene chloride. Dry the methylene chloride layer with anhydrous magnesium sulfate. Distillation of methylene chloride under reduced pressure yields a liquid. This was washed with hexane and crystallized to produce white crystals of (5S)-3-t-butyl-5-hydroxymethyl-oxazolidin-2-one.
0.8g is obtained. [α] 20 D = +44.7° (C = 1, CHCl 3 )

Claims (1)

【特蚱請求の範囲】  䞀般匏 〔※は䞍斉炭玠を瀺す。R1はC1〜C4の䜎玚ア
ルキル基を瀺す。R2はC1〜C4の䜎玚アルキル基、
ベンゞル基又は眮換ベンゞル基を瀺す。〕 で衚わされる光孊掻性゚ポキシ化合物を、酞ず反
応させるこずを特城ずする、 䞀般匏 〔※は䞍斉炭玠を瀺す。R1はC1〜C4の䜎玚ア
ルキル基を瀺す。〕 で衚わされる出発物質の立䜓配眮が反転した光孊
掻性−ヒドロキシメチル−−眮換オキサゟリ
ゞン−−オンの補造法。  R1が−ブチル基又はむ゜プロピル基であ
る特蚱請求の範囲第項蚘茉の補造法。  R2がメチル基又ぱチル基である特蚱請求
の範囲第項たたは第項蚘茉の補造法。  酞が鉱酞又は有機酞である特蚱請求の範囲第
項蚘茉の補造法。  鉱酞が塩酞である特蚱請求の範囲第項蚘茉
の補造法。  有機酞が酢酞である特蚱請求の範囲第項蚘
茉の補造法。  酞がルむス酞である特蚱請求の範囲第項蚘
茉の補造法。
[Claims] 1. General formula [* indicates an asymmetric carbon. R 1 represents a C 1 to C 4 lower alkyl group. R 2 is a C 1 to C 4 lower alkyl group,
Indicates a benzyl group or a substituted benzyl group. ] The general formula is characterized in that an optically active epoxy compound represented by is reacted with an acid. [* indicates an asymmetric carbon. R 1 represents a C 1 to C 4 lower alkyl group. ] A method for producing an optically active 5-hydroxymethyl-N-substituted oxazolidin-2-one in which the configuration of the starting material is inverted. 2. The manufacturing method according to claim 1, wherein R 1 is a t-butyl group or an isopropyl group. 3. The manufacturing method according to claim 1 or 2, wherein R 2 is a methyl group or an ethyl group. 4. The production method according to claim 1, wherein the acid is a mineral acid or an organic acid. 5. The manufacturing method according to claim 4, wherein the mineral acid is hydrochloric acid. 6. The manufacturing method according to claim 4, wherein the organic acid is acetic acid. 7. The production method according to claim 1, wherein the acid is a Lewis acid.
JP17558583A 1983-09-22 1983-09-22 Production of optically active oxazolidin-2-one derivative Granted JPS6067470A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17558583A JPS6067470A (en) 1983-09-22 1983-09-22 Production of optically active oxazolidin-2-one derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17558583A JPS6067470A (en) 1983-09-22 1983-09-22 Production of optically active oxazolidin-2-one derivative

Publications (2)

Publication Number Publication Date
JPS6067470A JPS6067470A (en) 1985-04-17
JPH045026B2 true JPH045026B2 (en) 1992-01-30

Family

ID=15998652

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17558583A Granted JPS6067470A (en) 1983-09-22 1983-09-22 Production of optically active oxazolidin-2-one derivative

Country Status (1)

Country Link
JP (1) JPS6067470A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075576B2 (en) * 1989-07-12 1995-01-25 ダむ゜ヌ株匏䌚瀟 Process for producing optically active amino compounds
JPH0344381A (en) * 1989-07-12 1991-02-26 Daiso Co Ltd Optically active oxazolidinone derivative
EP0670305B1 (en) * 1993-09-20 1998-05-20 Kaneka Corporation Process for producing 3-amino-2-hydroxy-1-propanol derivative

Also Published As

Publication number Publication date
JPS6067470A (en) 1985-04-17

Similar Documents

Publication Publication Date Title
US5225585A (en) Production of fluoxetine and new intermediates
EP1077212B1 (en) Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
BG64986B1 (en) Method for the preparation of 5-cyanophthalide
HU186776B (en) Process for preparing new, optically active imidazolidin-2-one derivatives
JP3351563B2 (en) Method for producing 3-hydroxybutyric acid derivative
JPS62277375A (en) Manufacture of alpha-substituted gamma-butyrolactone
JP2006525294A (en) Process for producing 4-hydroxyisoleucine and its derivatives
WO1999003852A1 (en) Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
US5932758A (en) Process for the production β-amino-α-hydroxycarboxylic acids and derivatives thereof
JPH0517214B2 (en)
JPH021827B2 (en)
US2791595A (en) Long chain esters of nitrophenylaminopropanediols and preparation thereof
US5840964A (en) Process for the preparation of the enantiomers of 2-(2-fluoro-4-biphenyl)propionic acid
US5744630A (en) Method of producing 3-amino-2-hydroxy-1-propanol derivatives
JPH0124782B2 (en)
KR100241263B1 (en) Process for preparing n-alkyloxycarbonyl-beta-alkylsufonvaline
KR100850558B1 (en) Efficient preparation of atorvastatin
JPH0637449B2 (en) Process for producing optically active atenolol and its intermediates
JPH0480896B2 (en)
JPH051002A (en) Method for producing α-amino acid
JPH0316339B2 (en)
JP3632979B2 (en) Method for producing 2-aminomalonic acid derivative and 2-amino-1,3-propanediol derivative
JPS6067470A (en) Production of optically active oxazolidin-2-one derivative
JPWO2002044136A1 (en) Method for producing N-protected-β-amino alcohol and method for producing N-protected-β-aminoepoxide
JP2002308841A (en) Process for producing optically active 3-amino-3- (2-hydroxyaryl) propionic acid and esters thereof